Literature DB >> 4536807

Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.

A D Schreiber, M M Frank.   

Abstract

A model which permits evaluation in molecular terms of the role of antibody and of complement in the immune destruction of erythrocytes was established in the guinea pig. IgM and IgG immunoglobulins were isolated from rabbit anti-guinea pig erythrocyte antisera and were used to sensitize (51)Cr-labeled guinea pig erythrocytes. The average number of complement-fixing sites per erythrocyte formed by antibody was determined for each of the various preparations by the Cla fixation and transfer test. The rate of clearance and of organ localization was determined for cells sensitized with either IgM or IgG antibodies, and dose-response curves were established in normal guinea pigs and guinea pigs with a genetically controlled, complete absence of the fourth component of complement (C4). At least 60 complement-fixing sites per cell were required for accelerated clearance of IgM-sensitized erythrocytes. The bulk of cells with IgM sites were cleared by the liver within 5 min after injection and were then slowly returned to the circulation where they survived normally. There was no accelerated clearance whatsoever of IgM-sensitized erythrocytes in C4-deficient guinea pigs. As few as 1.4 IgG complement-fixing sites per cell resulted in decreased erythrocyte survival. There was no evidence of immediate tissue sequestration and release. Progressive trapping and destruction of erythrocytes by the spleen was responsible for most of the clearance of IgG-sensitized cells. Clearance of IgG-sensitized cells was markedly impaired in guinea pigs with C4 deficiency; however, there was some decrease over normal survival. The data indicate that IgG and IgM antibodies interact with complement in vivo by mechanisms which are qualitatively or quantitatively different and produce different biologic effects.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4536807      PMCID: PMC302163          DOI: 10.1172/JCI106846

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  STUDIES ON THE ROLE OF COMPLEMENT IN THE IMMUNE CLEARANCE OF ESCHERICHIA COLI AND RAT ERYTHROCYTES BY THE RETICULOENDOTHELIAL SYSTEM IN MICE.

Authors:  H L SPIEGELBERG; P A MIESCHER; B BENACERRAF
Journal:  J Immunol       Date:  1963-05       Impact factor: 5.422

2.  The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms.

Authors:  J H JANDL; A R JONES; W B CASTLE
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

3.  Acquired Haemolytic Anaemia: Survival of Transfused Erythrocytes in Patients and Normal Recipients.

Authors:  J G Selwyn; W E Hackett
Journal:  J Clin Pathol       Date:  1949-05       Impact factor: 3.411

4.  Immune mechanisms for destruction of erythrocytes in vivo. I. The effect of IgG rabbit antibodies on rat erythrocytes.

Authors:  B Vitale; M E Kaplan; R E Rosenfield; S Kochwa
Journal:  Transfusion       Date:  1967 Jul-Aug       Impact factor: 3.157

5.  The C'la fixation and transfer test: examples of its applicability to the detection and enumeration of antigens and antibodies at cell surfaces.

Authors:  T Borsos; H R Colten; J S Spalter; N Rogentine; H J Rapp
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

Review 6.  The role of complement in antibody-mediated red-cell destruction.

Authors:  P L Mollison
Journal:  Br J Haematol       Date:  1970-03       Impact factor: 6.998

7.  Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage.

Authors:  M M Frank; R R Dourmashkin; J H Humphrey
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

8.  The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits.

Authors:  D L Brown; P J Lachmann; J V Dacie
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

9.  The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies.

Authors:  M M Frank; T Gaither
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

10.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

View more
  60 in total

Review 1.  Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Authors:  S Izui; L Fossati-Jimack; S A da Silveira; T Moll
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

Review 3.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis.

Authors:  Maria Allhorn; Juana G Briceño; Lucie Baudino; Christian Lood; Martin L Olsson; Shozo Izui; Mattias Collin
Journal:  Blood       Date:  2010-03-31       Impact factor: 22.113

Review 5.  Lessons learned from mouse models of hemolytic transfusion reactions.

Authors:  Eldad A Hod; James C Zimring; Steven L Spitalnik
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

6.  Pathogenesis of hemolysis in immune hemolytic anemia.

Authors:  J R Cohen
Journal:  West J Med       Date:  1977-10

7.  Demonstration of hepatic Fc receptor function in vivo.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

8.  Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.

Authors:  Nisar A Baig; Ronald P Taylor; Margaret A Lindorfer; Amy K Church; Betsy R LaPlant; Adam M Pettinger; Tait D Shanafelt; Grzegorz S Nowakowski; Clive S Zent
Journal:  J Immunol       Date:  2014-01-15       Impact factor: 5.422

Review 9.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

10.  The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.

Authors:  C J Jaffe; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.